BIO UV Group (ALTUV) - Net Assets
Based on the latest financial reports, BIO UV Group (ALTUV) has net assets worth €40.53 Million EUR (≈ $47.38 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€69.21 Million ≈ $80.91 Million USD) and total liabilities (€28.68 Million ≈ $33.53 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore total assets of BIO UV Group for the complete picture of this company's asset base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €40.53 Million |
| % of Total Assets | 58.56% |
| Annual Growth Rate | 23.33% |
| 5-Year Change | 32.04% |
| 10-Year Change | N/A |
| Growth Volatility | 58.74 |
BIO UV Group - Net Assets Trend (2016–2025)
This chart illustrates how BIO UV Group's net assets have evolved over time, based on quarterly financial data. Check tangible net worth ratio of BIO UV Group to evaluate the tangible quality of the company's equity base.
Annual Net Assets for BIO UV Group (2016–2025)
The table below shows the annual net assets of BIO UV Group from 2016 to 2025. For live valuation and market cap data, see ALTUV market cap overview.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €40.53 Million ≈ $47.38 Million |
+23.99% |
| 2024-12-31 | €32.69 Million ≈ $38.21 Million |
+1.45% |
| 2023-12-31 | €32.22 Million ≈ $37.67 Million |
-0.38% |
| 2022-12-31 | €32.34 Million ≈ $37.81 Million |
+5.37% |
| 2021-12-31 | €30.70 Million ≈ $35.89 Million |
+1.65% |
| 2020-12-31 | €30.20 Million ≈ $35.30 Million |
+88.70% |
| 2019-12-31 | €16.00 Million ≈ $18.71 Million |
-4.51% |
| 2018-12-31 | €16.76 Million ≈ $19.59 Million |
+179.18% |
| 2017-12-31 | €6.00 Million ≈ $7.02 Million |
-2.23% |
| 2016-12-31 | €6.14 Million ≈ $7.18 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to BIO UV Group's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 48.5% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €836.34K | 2.07% |
| Common Stock | €14.15 Million | 34.98% |
| Other Comprehensive Income | €7.17 Million | 17.72% |
| Other Components | €18.31 Million | 45.23% |
| Total Equity | €40.47 Million | 100.00% |
BIO UV Group Competitors by Market Cap
The table below lists competitors of BIO UV Group ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Khind Holdings Bhd
KLSE:7062
|
$19.00 Million |
|
Asiaplast Industries Tbk
JK:APLI
|
$19.00 Million |
|
Orbital Corporation Ltd
AU:OEC
|
$19.01 Million |
|
Getin Holding SA
WAR:GTN
|
$19.01 Million |
|
Matricelf Ltd
TA:MTLF
|
$18.97 Million |
|
ASIASOFT CORP.-NVDR-05
F:5ASA
|
$18.97 Million |
|
Hubei Geoway Investment Co Ltd
SHG:600462
|
$18.96 Million |
|
Sirius Real Estate Limited
LSE:SRE
|
$18.95 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in BIO UV Group's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 32,686,624 to 40,466,940, a change of 7,780,316 (23.8%).
- Net income of 836,336 contributed positively to equity growth.
- Share repurchases of 581,424 reduced equity.
- New share issuances of 7,716,513 increased equity.
- Other comprehensive income increased equity by 7,170,845.
- Other factors decreased equity by 7,361,954.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €836.34K | +2.07% |
| Share Repurchases | €581.42K | -1.44% |
| Share Issuances | €7.72 Million | +19.07% |
| Other Comprehensive Income | €7.17 Million | +17.72% |
| Other Changes | €-7.36 Million | -18.19% |
| Total Change | €- | 23.80% |
Book Value vs Market Value Analysis
This analysis compares BIO UV Group's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.46x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 1.68x to 0.46x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | €0.78 | €1.31 | x |
| 2017-12-31 | €0.77 | €1.31 | x |
| 2018-12-31 | €2.17 | €1.31 | x |
| 2019-12-31 | €2.06 | €1.31 | x |
| 2020-12-31 | €3.40 | €1.31 | x |
| 2021-12-31 | €2.91 | €1.31 | x |
| 2022-12-31 | €3.09 | €1.31 | x |
| 2023-12-31 | €3.17 | €1.31 | x |
| 2024-12-31 | €3.16 | €1.31 | x |
| 2025-12-31 | €2.86 | €1.31 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently BIO UV Group utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 2.07%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 2.33%
- • Asset Turnover: 0.52x
- • Equity Multiplier: 1.71x
- Recent ROE (2.07%) is below the historical average (3.11%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 20.95% | 13.27% | 0.56x | 2.82x | €667.40K |
| 2017 | -1.52% | -0.90% | 0.57x | 2.98x | €-691.63K |
| 2018 | 0.28% | 0.37% | 0.44x | 1.70x | €-1.63 Million |
| 2019 | -2.80% | -2.24% | 0.55x | 2.27x | €-2.05 Million |
| 2020 | 1.93% | 1.81% | 0.62x | 1.72x | €-2.44 Million |
| 2021 | 2.26% | 2.06% | 0.41x | 2.66x | €-2.36 Million |
| 2022 | 7.50% | 4.71% | 0.69x | 2.30x | €-806.12K |
| 2023 | 0.39% | 0.29% | 0.60x | 2.22x | €-3.10 Million |
| 2024 | 0.10% | 0.08% | 0.60x | 2.02x | €-3.24 Million |
| 2025 | 2.07% | 2.33% | 0.52x | 1.71x | €-3.21 Million |
Industry Comparison
This section compares BIO UV Group's net assets metrics with peer companies in the Pollution & Treatment Controls industry.
Industry Context
- Industry: Pollution & Treatment Controls
- Average net assets among peers: $3,601,198
- Average return on equity (ROE) among peers: -16.01%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| BIO UV Group (ALTUV) | €40.53 Million | 20.95% | 0.71x | $18.98 Million |
| UV Germi SA (ALUVI) | $5.90 Million | -14.74% | 0.32x | $9.40 Million |
| Osmosun SA (ALWTR) | $1.30 Million | -17.28% | 4.21x | $9.00 Million |
About BIO UV Group
BIO-UV Group S.A. designs, manufactures, and markets water treatment and disinfectant systems using ultraviolet, salt electrolysis, ozone, and advanced oxidation for individuals and professionals in France, rest of Europe, Asia, the Middle East, the Americas, and internationally. It operates through Products, Solutions, and After-Sales divisions. The company offers disinfection equipment and syst… Read more